Attendo AB (publ) (ATT.ST)
SEK 62.7
(-0.63%)
SEK 62.7
(-0.63%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 13.82 Billion SEK | -3.3% |
| 2022 | 14.29 Billion SEK | 6.99% |
| 2021 | 13.36 Billion SEK | 9.0% |
| 2020 | 12.26 Billion SEK | 3.75% |
| 2019 | 11.81 Billion SEK | 381.74% |
| 2018 | 2.45 Billion SEK | -48.48% |
| 2017 | 4.76 Billion SEK | 76.73% |
| 2016 | 2.69 Billion SEK | -3.72% |
| 2015 | 2.79 Billion SEK | -33.08% |
| 2014 | 4.18 Billion SEK | -0.1% |
| 2013 | 4.18 Billion SEK | 16.18% |
| 2012 | 3.6 Billion SEK | -49.09% |
| 2011 | 7.07 Billion SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 16.13 Billion SEK | 10.21% |
| 2024 Q1 | 14.64 Billion SEK | 5.91% |
| 2024 Q3 | 2.31 Billion SEK | -0.33% |
| 2023 FY | 13.82 Billion SEK | -3.3% |
| 2023 Q1 | 15.25 Billion SEK | 6.67% |
| 2023 Q2 | 15.35 Billion SEK | 0.67% |
| 2023 Q4 | 13.82 Billion SEK | -5.39% |
| 2023 Q3 | 14.61 Billion SEK | -4.82% |
| 2022 Q1 | 13.76 Billion SEK | 2.96% |
| 2022 FY | 14.29 Billion SEK | 6.99% |
| 2022 Q4 | 14.29 Billion SEK | -0.08% |
| 2022 Q3 | 14.3 Billion SEK | 1.37% |
| 2022 Q2 | 14.11 Billion SEK | 2.59% |
| 2021 FY | 13.36 Billion SEK | 9.0% |
| 2021 Q3 | 13.44 Billion SEK | 2.06% |
| 2021 Q4 | 13.36 Billion SEK | -0.62% |
| 2021 Q1 | 13.11 Billion SEK | 6.93% |
| 2021 Q2 | 13.17 Billion SEK | 0.5% |
| 2020 FY | 12.26 Billion SEK | 3.75% |
| 2020 Q2 | 12.8 Billion SEK | -2.52% |
| 2020 Q3 | 12.89 Billion SEK | 0.74% |
| 2020 Q4 | 12.26 Billion SEK | -4.95% |
| 2020 Q1 | 13.13 Billion SEK | 11.15% |
| 2019 Q3 | 11.24 Billion SEK | 0.39% |
| 2019 Q4 | 11.81 Billion SEK | 5.1% |
| 2019 Q1 | 10.67 Billion SEK | 335.22% |
| 2019 FY | 11.81 Billion SEK | 381.74% |
| 2019 Q2 | 11.2 Billion SEK | 4.91% |
| 2018 Q2 | 4.92 Billion SEK | 4.33% |
| 2018 FY | 2.45 Billion SEK | -48.48% |
| 2018 Q3 | 4.84 Billion SEK | -1.44% |
| 2018 Q1 | 4.71 Billion SEK | -0.95% |
| 2018 Q4 | 2.45 Billion SEK | -49.41% |
| 2017 Q2 | 2.89 Billion SEK | 9.12% |
| 2017 Q3 | 3.25 Billion SEK | 12.5% |
| 2017 Q4 | 4.76 Billion SEK | 46.13% |
| 2017 FY | 4.76 Billion SEK | 76.73% |
| 2017 Q1 | 2.65 Billion SEK | -1.48% |
| 2016 Q4 | 2.69 Billion SEK | -10.08% |
| 2016 Q3 | 2.99 Billion SEK | 9.18% |
| 2016 Q1 | 2.69 Billion SEK | -3.75% |
| 2016 FY | 2.69 Billion SEK | -3.72% |
| 2016 Q2 | 2.74 Billion SEK | 1.89% |
| 2015 FY | 2.79 Billion SEK | -33.08% |
| 2015 Q4 | 2.79 Billion SEK | -32.32% |
| 2015 Q3 | 4.13 Billion SEK | 0.0% |
| 2015 Q1 | 1.08 Billion SEK | -74.07% |
| 2014 Q4 | 4.18 Billion SEK | 0.0% |
| 2014 FY | 4.18 Billion SEK | -0.1% |
| 2013 FY | 4.18 Billion SEK | 16.18% |
| 2012 FY | 3.6 Billion SEK | -49.09% |
| 2011 FY | 7.07 Billion SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Ambea AB (publ) | 10.73 Billion SEK | -28.746% |
| Humana AB (publ) | 4.34 Billion SEK | -218.425% |
| ProstaLund AB (publ) | -14.01 Million SEK | 98737.369% |